Clinical response to EPA supplementation in patients with major depressive disorder is associated with higher plasma concentrations of pro-resolving lipid mediators

Chronic inflammation has been implicated in the pathophysiology of major depressive disorder (MDD). Activating the resolution of inflammation through ω-3 fatty acid supplementation may prove to be a successful therapeutic strategy for the treatment of MDD. Patients with MDD, body mass index >25 k...

Descripción completa

Detalles Bibliográficos
Autores principales: Lamon-Fava, Stefania, Liu, Minying, Dunlop, Boadie W., Kinkead, Becky, Schettler, Pamela J., Felger, Jennifer C., Ziegler, Thomas R., Fava, Maurizio, Mischoulon, David, Rapaport, Mark Hyman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10156711/
https://www.ncbi.nlm.nih.gov/pubmed/36635595
http://dx.doi.org/10.1038/s41386-022-01527-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10156711/
https://www.ncbi.nlm.nih.gov/pubmed/36635595
http://dx.doi.org/10.1038/s41386-022-01527-7

Ejemplares similares